Vanesa Fernández-Moreira
banner
vanesafm-isqch.bsky.social
Vanesa Fernández-Moreira
@vanesafm-isqch.bsky.social
Tenured Scientist @ ISQCH (CSIC-UZ) Bioinorganic Chemistry Research Lab: Development of Photosensitisers, Chemotherapeutic and Theragnostic agents. https://sites.google.com/view/pdt-section-vfm-group
Reposted by Vanesa Fernández-Moreira
Thrilled to share that I’m a co-author of a new article recently published in Angewandte Chemie!
Huge thanks to @gassergroup.bsky.social , @martard.bsky.social , and Dan Gibson for the collaboration, support, and all the learning along the way. 🌟
#Research #Science

doi.org/10.1002/anie...
A Triple Threat Against Ovarian Cancer: Os(II)‐Pt(IV)‐Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction
A novel Os(II)-Pt(IV)-Ceritinib (Os-Pt-Cer) conjugate enables triple-action anticancer therapy by integrating photodynamic therapy, chemotherapy, and immunogenic cell death (ICD) induction into a sin...
doi.org
October 6, 2025 at 3:06 PM
Reposted by Vanesa Fernández-Moreira
Very glad to share our new paper in @chemicalscience.rsc.org on in cellulo catalysis using our cyclodextrins, in collaboration with @gassergroup.bsky.social and @cariouk.bsky.social team and with Sylvain Roland, Hugo Madec and Yanis Tigherghar
pubs.rsc.org/en/content/a...
October 1, 2025 at 3:47 PM
Reposted by Vanesa Fernández-Moreira
🚨 PhD Opportunity! 🚨
Join our group in Bioinorganic Chemistry to work on the synthesis & biological evaluation of metal complexes for anticancer therapy.
jobs.ruhr-uni-bochum.de/jobposting/8...
October 2, 2025 at 10:16 AM
Reposted by Vanesa Fernández-Moreira
Goodbye @martard.bsky.social! Many thanks for your hard work! We wish you all the very best for the start of your independent career in Zaragoza!
@chimieparistechpsl.bsky.social
September 29, 2025 at 12:39 PM
Reposted by Vanesa Fernández-Moreira
Second stop at ISQCH in Zaragoza. Had a fantastic day making new friends and discovering a very exciting department with lots of cool chemistry.
September 25, 2025 at 5:36 AM
Reposted by Vanesa Fernández-Moreira
Very happy to welcome two exchange PhD students: Eva Morales-Pioz from the group of @vanesafm-isqch.bsky.social and Guglielmo Spinelli from @nanobic.bsky.social. Enjoy your stays at @chimieparistechpsl.bsky.social
@cariouk.bsky.social
September 2, 2025 at 3:54 PM
Reposted by Vanesa Fernández-Moreira
Our chairs @albrecht-lab.bsky.social and @evaheviagroup.bsky.social are excited to welcome you to Bern and the opening #eucomc2025
July 6, 2025 at 2:06 PM
Reposted by Vanesa Fernández-Moreira
📸 A great moment at #LUCESCOSTAction in Zadar!
We gathered for the official group photo during the coffee break — celebrating collaboration, science, and new connections! 🌟🤝 @costprogramme.bsky.social
April 29, 2025 at 9:23 AM
Reposted by Vanesa Fernández-Moreira
Nice to see our recent article on the Front cover- now published in Inorganic Chemistry Frontiers. doi.org/10.1039/D4QI.... Great collaboration with @MarchanLab_UB.
April 30, 2025 at 4:52 AM
Reposted by Vanesa Fernández-Moreira
A simple guide to the design of metal complexes in luminescence and photoredox catalysis.

With Giacomo Morselli and Christian Reber in JACS @jacs.acspublications.org

pubs.acs.org/doi/10.1021/...
Molecular Design Principles for Photoactive Transition Metal Complexes: A Guide for “Photo-Motivated” Chemists
Luminescence and photochemistry involve electronically excited states that are inherently unstable and therefore spontaneously decay to electronic ground states, in most cases by nonradiative energy release that generates heat. This energy dissipation can occur on a time scale of 100 fs (∼10–13 s) and usually needs to be slowed down to at least the nanosecond (∼10–9 s) time scale for luminescence and intermolecular photochemistry to occur. This is a challenging task with many different factors to consider. An alternative emerging strategy is to target dissociative excited states that lead to metal–ligand bond homolysis on the subnanosecond time scale to access synthetically useful radicals. Based on a thorough review at the most recent advances in the field, this article aims to provide a concise guide to obtaining luminescent and photochemically useful coordination compounds with d-block elements. We hope to encourage “photo-motivated” chemists who have been reluctant to apply their synthetic and other knowledge to photophysics and photochemistry, and we intend to stimulate new approaches to the synthetic control of excited state behavior.
pubs.acs.org
March 27, 2025 at 10:18 PM
Reposted by Vanesa Fernández-Moreira
Exciting news! 🌟@BioCuidadReal25 will take place from June 2-4! Join us for an incredible conference on #BioinorganicChemistry featuring amazing plenary speakers! Christelle Hureau, @iottgroup.bsky.social, Ramon vilar and Petra Heffeter
February 19, 2025 at 7:44 AM
Reposted by Vanesa Fernández-Moreira
A novel arene osmium(ii) complex as an effective rhabdomyosarcoma cancer stem cell agent - now published in InorgChemFront in collaboration with Viktor Brabec pubs.rsc.org/en/content/a... Congrats to all the co-authors.
A novel benzothiazole-1,2,3-triazole-based arene osmium(II) complex as an effective rhabdomyosarcoma cancer stem cell agent
We designed a series of pseudo-octahedral arene Os(ii) complexes (Os1–Os5) with the general formula [(η6-p-cym)Os(BTAT)Cl]+, where BTAT represents chelating N^N′ ligands based on the 1-aryl-4-benzothi...
pubs.rsc.org
January 17, 2025 at 7:00 PM
Reposted by Vanesa Fernández-Moreira
Come join us for our biannual meeting in Ciudad Real!

More info here:
www.biociudadreal.es
January 16, 2025 at 10:52 AM
Reposted by Vanesa Fernández-Moreira
📣 Attention #chemsky:
Nominate an emerging leader in Bioinorganic and Medicinal Inorganic Chemistry for the Jonathan L. Sessler Fellowship
📅 Deadline: January 31
All info: www.acs.org/funding/scho...

Please tell all your colleagues on and off 🦋
The Jonathan L. Sessler Fellowship for Emerging Leaders in Bioinorganic and Medicinal Inorganic Chemistry - American Chemical Society
American Chemical Society: Chemistry for Life.
www.acs.org
January 13, 2025 at 3:12 PM
Reposted by Vanesa Fernández-Moreira
🌟 Starting the year with exciting news! Our Frontier paper is now out in @daltontrans.bsky.social
💡Breaking the deep-red light absorption barrier of iridium(iii)-based PSs.
👉🏻https://pubs.rsc.org/en/content/articlelanding/2025/dt/d4dt03014a
@joseruizlab.bsky.social @gassergroup.bsky.social
January 10, 2025 at 9:05 AM
Reposted by Vanesa Fernández-Moreira
Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer | Inorganic Chemistry pubs.acs.org/doi/10.1021/... Ren, Gao, and co-workers @InorgChem #iridium #Ir2 #PDT #PTT #ROS #IR
January 7, 2025 at 6:00 PM
Reposted by Vanesa Fernández-Moreira
Super excited to launch with @albrecht-lab.bsky.social the #bluesky account #EUCOMC2025 @eucomc2025.bsky.social
Come to #Bern in July 6-10 2025 for a feast of #organometallic #chemistry and to discover one of the nicest cities in the world🇨🇭! #SCS #EuChemS Follow the account for further details!
The EUCOMCXXVI will be held in the beautiful city of Bern Switzerland in July 6 - 10, 2025. We look forward to welcome you all! Follow this #bluesky account for updates and to find out a bit more about our exciting line up of speakers #SCS #euchems @unibern.bsky.social
eucomc2025.scg.ch
January 10, 2025 at 9:57 AM
Reposted by Vanesa Fernández-Moreira
Check out our article in Dalton Trans. about a Necrosis Inducing Tetranuclear Ru(II)-Re(I) complex for Anticancer Therapy. Congrats to Julia, Eleni, Stephan, and @nmontesdeocas.bsky.social ! @ruhr-uni-bochum.de dx.doi.org/10.1039/D4DT...
December 18, 2024 at 1:54 PM
Reposted by Vanesa Fernández-Moreira
Merry Christmas and Happy New Year 2025! Our best wishes for all of you!
December 19, 2024 at 8:24 PM
Reposted by Vanesa Fernández-Moreira
Check out our article in J. Med. Chem. @acsmedi.bsky.social about the Combinatorial Synthesis toward the Discovery of Highly Cytotoxic Fe(III) Complexes. Congrats to Felix, Lisa, Zisis, and @nmontesdeocas.bsky.social ! @ruhr-uni-bochum.de pubs.acs.org/doi/10.1021/...
December 17, 2024 at 7:33 AM
Reposted by Vanesa Fernández-Moreira
Glad to share our recent paper in collaboration with Prof. Brabec, published in JMC. Congrats to all co-authors!
pubs.acs.org/doi/full/10....
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent
Herein, we describe and investigate biological activity of three octahedral ruthenium(II) complexes of the type [Ru(C∧N)(phen)2]+, RuL1–RuL3, containing a π-expansive cyclometalating substituted benzo[g]quinoxaline ligand (C∧N ligand) (phen = 1,10-phenanthroline). Compounds RuL1–RuL3 in cervical, melanoma, and colon human cancer cells exhibit high phototoxicity after irradiation with light (particularly blue), with the phototoxicity index reaching 100 for the complex RuL2 in most sensitive HCT116 cells. RuL2 accumulates in the cellular membranes. If irradiated, it induces lipid peroxidation, likely connected with photoinduced ROS generation. Oxidative damage to the fatty acids leads to the attenuation of the membranes, the activation of caspase 3, and the triggering of the apoptotic pathway, thus implementing membrane-localized photodynamic therapy. RuL2 is the first photoactive ruthenium-based complex capable of killing the hardly treatable colon cancer stem cells, a highly resilient subpopulation within a heterogeneous tumor mass, responsible for tumor recurrence and the metastatic progression of cancer.
pubs.acs.org
December 9, 2024 at 9:02 AM
Reposted by Vanesa Fernández-Moreira
Check out our paper in J. Biol. Inorg. Chem. @springer1842.bsky.social about the shift of cell death mechanism in primary human neutrophils upon treatment with a Ru(II) polypyridine complex. Great collaboration with the Kruss Group! Congrats Nicolas and Jennifer! dx.doi.org/10.1007/s007...
December 14, 2024 at 12:13 PM
Reposted by Vanesa Fernández-Moreira
Mitochondria Localized Anticancer Iridium(III) Prodrugs for Targeted Delivery of Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors and Cytotoxic Iridium(III) Complex | Inorganic Chemistry pubs.acs.org/doi/10.1021/... Venkatesh & co-workers @InorgChem #iridium #mitochondria #Mcl_1 #esterase
December 13, 2024 at 6:08 AM